Since the FDA first approved the use of gene therapy in 2017, the market for these treatments has expanded rapidly. With the aim of replacing faulty genes with healthy ones, gene therapy focuses on diseases which are either difficult or impossible to cure using more...
In the decades James Neal spent in systems implementation and consulting for pharmaceuticals, he identified a gap at a critical point in the lifecycle of clinical, pre-revenue pharmaceutical companies. The move from stage 1 clinical trials to stages 2 and 3 happened...
